Market Place
Sourcing Support
All News #Library
Biotech
ILiad Advances Whooping Cough Vaccine With $115M Raise
10 Feb 2026 //
FIERCE BIOTECH
Iliad Biotech Reveals BPZE1 Phase 2B Results In Lancet Microbe
02 Dec 2025 //
BUSINESSWIRE
ILiAD and hVIVO Sign LOI for BPZE1 Phase 3 Pertussis Vaccine Trial
27 Jan 2025 //
BUSINESSWIRE
ILiAD Biotechnologies To Participate In Investor Conferences
01 Oct 2024 //
BUSINESSWIRE
ILiAD Selects Emmes Group To Conduct Phase III Pertussis Vaccine Studies
24 Jun 2024 //
CONTRACT PHARMA
ILiAD`s pertussis shot joins Trojan horse of childhood vaccines
28 May 2024 //
FIERCE BIOTECH
ILiAD Bio: Positive Phase 2b School-Age Data For Pertussis Vaccine BPZE1
28 May 2024 //
BUSINESSWIRE
ILiAD Announces Presentation at the 2023 World Vaccine Congress in Barcelona
18 Oct 2023 //
BUSINESSWIRE
ILiAD says homer hit in whooping cough vaccine challenge trial
08 Sep 2023 //
FIERCE BIOTECH
ILiAD Reports Demonstration of Protection Against B. pertussis Colonization
05 Sep 2023 //
BUSINESSWIRE
ILiAD Biotechnologies Announces Presentation at the World Vaccine Congress
05 Apr 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.